Pharmaceutical Commerce - November/December 2015

Accenture, Cognizant and PwC more or less tie for their capabilities in life sciences sales & marketing consulting, says IDC

PDI had been struggling with a customer dataset of millions of physicians, nurse practitioners, pharmacists and other healthcare professionals (HCPs)

Zephyr Illuminate pools disparate data for predictive analytics for commercial operations

'European companies will not be able to follow the exact path to operational compliance as their US counterparts,' says IMS Health survey

A Common Universal Patient de-IDentifier could greatly enhance the value of industry data assets

Fees paid to FDA by small generic manufacturers are financially 'unfair'

Are hubs a help or hindrance in getting patients on therapy?

A contractual arrangement that could save time and money for brand owners

Market study puts global activity at $2.93 billion in 2015

While temperature-controlled components advance, service providers are identifying innovative refinements to basic shipping services

Even with legislative incentives, pharma manufacturers struggle to cost-justify pediatric innovation

European experience to date indicates a changing perspective on biosimilar pricing

The right studies at the right time in the right way to meet real-world evidence needs

Packaging-line engineers are going into overdrive as industry gets ready for the 2017 unit-serialization mandate

Model N/Highpoint survey points to better integration of pricing and contract data

Company has 18 products in its US pipeline

Quality control remains a problem among compounding pharmacies, but bigger players are entering the field

More cold chain capacity as well

Biennial survey finds growing awareness of information options by consumers

Xerox subsidiary expands its call-center operations to include specialty reimbursement services

Student entries will compete for an award in addition to the commercial contest